We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

This dividend share yields under 1% — but I’d still buy it

This dividend share has a low yield. So why would our writer consider adding it to his income portfolio?

| More on:
pensive bearded business man sitting on chair looking out of the window

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Often when looking at dividend shares, it can be tempting to zoom in on high yields. Over time, big dividend yields can be very rewarding. I certainly own some high-yielders in my portfolio.

But sometimes, a dividend share attracts me despite a small current payout — because of what I think it might deliver in future.

Should you buy Judges Scientific Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Focussed business model

An example of this is Judges Scientific (LSE: JDG). If you have never heard of this company, you are not alone. It operates in a niche sector, supplying scientific instruments to customers like universities, commercial labs, and research agencies.

The company management figured out that this industry is highly fragmented. In other words, there are lots of instrument makers that are very small. Some have just a handful of employees, and when the owner retires they may simply wind up the business.

That presents an opportunity for a company like Judges. With limited competition from other bidders, it is able to buy many such small manufacturers at attractive valuations. Focussing on a single area helps to grow Judges’ expertise. So it can help the companies it acquires with things like strategic advice and access to capital. Aside from that, it tends to leave them alone to focus on what they do best.

Profit potential

So far, so good. But what makes this business model attractive from an income perspective?

When it comes to scientific instruments, accuracy and reliability are the name of the game. That means that purchasing decisions tend not to be driven by cost. Instead, customers are looking for a very high level of quality.

That gives a company like Judges pricing power. It can set prices without worrying too much about competition from low-cost producers, for example. By building a reputation for product quality in a specialist area, over time its revenues have grown but not at the cost of attractive profit margins.

Dividend share with growth potential

Last year, the firm made post-tax profits of £13m on revenue of £91m. That sort of profit margin attracts me. As it continues to grow through its acquisitive strategy, I reckon Judges can hopefully keep growing earnings.

At the moment, the dividend yield is only 0.9%. That is low and not especially attractive to me. But what I do like is Judges’ aggressive approach to growing the dividend. Last year saw dividend growth of 20%. The year before was a more modest but still impressive 10%, while before that the payout had increased by 25% for two years in a row.

Past performance is not necessarily indicative of what will come next. But I think Judges’ history of double-digit percentage dividend increases reflects the lucrative nature of its business model. Admittedly, that may not continue. Ongoing pandemic restrictions in some markets may lead to sales being postponed or cancelled. Other companies could copy Judges’ business model, pushing up the purchase price for acquisitions and hurting profit margins.

But so far, Judges has impressed me with its strategy and ability to deliver strong dividend growth. I would consider buying this dividend share for my portfolio not because of its current yield, but the potential for ongoing growth in the payout.

Christopher Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Judges Scientific. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Happy senior couple hugging and enjoying retirement at home
Investing Articles

Here’s why I bought this 7.6%-yielding FTSE 100 dividend stock instead of saving in a Cash ISA

Harvey Jones crunches the numbers to show how investing in stocks and shares can be much more profitable than saving…

Read more »

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

Here’s how much passive income 1,000 Greggs shares could pay…

Greggs shares have lost nearly 50% of their value inside the past two years. Is this out-of-favour passive income stock…

Read more »

Overjoyed exited middle aged married couple giving high five, finishing doing domestic paperwork together at home. Euphoric happy older mature spouses celebrating successful investment or purchase.
Investing Articles

This beaten-down FTSE 100 dividend share just jumped 11% in a week but still yields almost 5%

Harvey Jones has been highlighting this dividend share opportunity for weeks and suddenly it's showing signs of life. Can the…

Read more »

Investing Articles

Down 53% since May, is this SpaceX-backed UK stock now in the bargain bin?

The Filtronic (LSE:FTC) share price has come crashing back down to earth in recent weeks. Has the selling gone too…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

3,566 shares in this FTSE 100 stalwart earns a £1,443 second income

Stephen Wright sees Unilever's battered share price as an attractive option for investors looking for a second income to consider.

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

3 stocks I’m looking to buy in July

Stephen Wright’s stocks to buy list for July includes a specialist chemicals recovery play, a quiet infrastructure compounder, and an…

Read more »

ISA Individual Savings Account
Investing Articles

How do the government’s latest changes affect your Stocks and Shares ISA?

Stephen Wright explains what the new anti-circumvention rules mean for investors with uninvested cash in their Stocks and Shares ISAs.

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

Here’s how much I think Rolls-Royce shares will be worth by the end of 2027

Ken Hall is considering buying Rolls-Royce shares. But just how much further could the stock climb by the end of…

Read more »